JNJ-95298177

· Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JNJ-95298177, covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer [Phase 1]